Results 211 to 220 of about 59,332 (342)

Mucosal‐Associated Invariant T Cells in Rheumatic Diseases

Arthritis &Rheumatology, EarlyView.
Mucosal‐associated invariant T (MAIT) cells are innate‐like T cells defined by their semi‐invariant T cell receptor and restriction by the major histocompatibility complex class I–related molecule (MR1). These cells are primarily activated by microbial‐derived metabolites presented by MR1 or by cytokines.
Manon Lesturgie‐Talarek, Virginie Gonzalez, Lucie Beaudoin, Noémie Sénot, Corinne Miceli‐Richard, Yannick Allanore, Agnès Lehuen, Jerôme Avouac   +7 more
wiley   +1 more source

A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritis

Arthritis &Rheumatology, Accepted Article.
Background Individuals with serum elevations of anti‐cyclic citrullinated peptide (anti‐CCP) antibodies are at increased risk for future rheumatoid arthritis (RA). No pharmacologic interventions have been approved for the prevention of RA in such ‘at‐risk’ individuals. However, hydroxychloroquine (HCQ) is used without supporting clinical trial evidence.
Kevin D. Deane, Christopher C. Striebich, Marie L. Feser, James R. O'Dell, Judith A. James, Jeffrey A. Sparks, John M. Davis, Jonathan Graf, Maureen A. McMahon, Elizabeth B. Solow, Lindsy Forbess, Athan Tiliakos, Elena Schiopu, Maria I. Danila, Diane L. Horowitz, Jonathan Kay, Colin D. Strickland, Joel M. Guthridge, Cristina Arriens, Jennifer M. Grossman, M. Kristen Demoruelle, Elizabeth A. Bemis, Ashley Frazer‐Abel, Chelsie L. Fleischer, David A. Fox, Ted R. Mikuls, Melissa Greenleaf, Kate York, Sarah Walker, Lynette Keyes‐Elstein, Margie Byron, Janel Fedler, Ellen A. Goldmuntz, V. Michael Holers   +33 more
wiley   +1 more source

Liquid Phase Catalytic Transfer Hydrogenation of Crotonaldehyde over ReO_x-Supported Catalysts Using Formic Acid as In Situ Hydrogen Donor. [PDF]

Molecules
Aristizábal-Alzate CE, Naharro-Ovejero V, Romero-Sáez M, Dongil AB.   +3 more
europepmc   +1 more source

Influence of Donor–Acceptor Distance Variation on Photoinduced Electron and Proton Transfer in Rhenium(I)–Phenol Dyads

, 2012
Martin Kuss‐Petermann, Hilke Wolf, Dietmar Stalke, Oliver S. Wenger   +3 more
openalex   +1 more source

Identification of histone deacetylase inhibitor targeting type I interferon and B‐cell abnormalities in systemic lupus erythematosus

Arthritis &Rheumatology, Accepted Article.
Objective Systemic lupus erythematosus (SLE) is characterized by increased type I interferon (IFN‐I) and autoantibody production. This study aimed to identify drugs that can inhibit both IFN‐I and autoantibody production. Methods We identified an inhibitor of IFN‐I production from a chemical library.
Takehiro Hirayama, Hachiro Konaka, Yasuhiro Kato, Takayuki Shibahara, Chisato Nishizawa, Kohei Tsujimoto, JeongHoon Park, Eri Itotagawa, Tatsunori Jo, Masayuki Nishide, Sumiyuki Nishida, Yoshihito Shima, Masashi Narazaki, Wataru Aoki, Ken J Ishii, Hyota Takamatsu, Atsushi Kumanogoh   +16 more
wiley   +1 more source

Exploring the determination of the standard rate constant in electrochemical metal deposition: theory and experiment. [PDF]

Chem Sci
Saad Guermeche R, Affoune AM, Houam S, Atek I, Vautrin-Ul C, Nacef M, Chelaghmia ML, Girault HH, Banks CE, Djaghout I, Bouteillon J, Poignet JC.   +11 more
europepmc   +1 more source

Exploring the exotic magnetism in Rhenium-based double perovskites using muon spin rotation

Dr Dharmalingan Prabhakaran, Dr Mark Telling, Dr Devashi Adroja, Dr Uthayakumar Sivaperumal   +3 more
openalex   +1 more source

Distinct Binding of Rhenium Catalysts on Nanostructured and Single-Crystalline TiO₂ Surfaces Revealed by Two-Dimensional Sum Frequency Generation Spectroscopy

, 2018
Heather Vanselous, Pablo E. Videla, Víctor S. Batista, Poul B. Petersen   +3 more
openalex   +2 more sources

Rhodium(III), Palladium(II) and Rhenium(I) Complexes with 7‐(Diphenylphosphine)‐indole and ‐indolate [PDF]

, 2013
Susanne Kammerer, Bernd Neumann, Brigitte Köhler, Péter Mayer, Ingo‐Peter Lorenz   +4 more
openalex   +1 more source

Linezolid prevents fibroblast activation and ameliorates tissue fibrosis by inhibition of mitochondrial translation

Arthritis &Rheumatology, Accepted Article.
Background Beyond its role as a ribosome‐targeting antibiotic, linezolid was recently shown to modulate immune responses by inhibiting mitochondrial translation. Since mitochondrial dysfunction is implicated in various fibrotic diseases, including systemic sclerosis (SSc), this study aimed to evaluate the antifibrotic potential of linezolid and ...
Xuezhi Hong, Yanhua Xiao, Haodong Qi, Shihao Zhu, Tim Filla, Andrea‐Hermina Györfi, Yi‐Nan Li, Meilin Xu, Langxian Zhi, Thuong Trinh‐Minh, Clara Dees, Georg Schett, Jörg H.W. Distler, Alexandru‐Emil Matei   +13 more
wiley   +1 more source